首页> 外文学位 >Molecular characterization and expression of Salmonella enterica serotype Enteritidis fimbrial genes in Escherichia coli.
【24h】

Molecular characterization and expression of Salmonella enterica serotype Enteritidis fimbrial genes in Escherichia coli.

机译:大肠杆菌中肠炎沙门氏菌血清型肠炎沙门氏菌纤维基因的分子表征和表达。

获取原文
获取原文并翻译 | 示例

摘要

Salmonella enterica serotype Enteritidis (S . Enteritidis) is perceived as an expanding pandemic and a significant threat to the human health worldwide. Consequently, numerous efforts to determine sources of outbreaks and to control this pathogen in farms have been made. To facilitate epidemiological investigations, isolates of S. Enteritidis, obtained from outbreak and source farms, are compared using typing methods to identify sources of infection of human outbreaks. Currently, molecular typing methods used to assess strains of S. Enteritidis phage type (PT) 4 are not able to consistently demonstrate differences among strains from distinct outbreaks. To improve the accuracy of S. Enteritidis PT 4 characterization and epidemiological studies, a number of molecular typing methods were evaluated and compared in their ability to discriminate S. Enteritidis PT 4 isolates from different origins. Furthermore, due to the relevance of S. Enteritidis to food safety, several attempts have been made to control of S. Enteritidis infection in poultry. However, currently available live attenuated and killed vaccines against S. Enteritidis have shown limited reduction in the colonization of S. Enteritidis in internal organs, intestines and cecum, providing incomplete protection to birds. As a result, there is an urgent need for a successful vaccine to protect ensure S. Enteritidis-free food products and, thus, reduce foodborne illnesses associated with the consumption of contaminated eggs and poultry products. Two live recombinant vaccine strains based on the sefA and sefABCD fimbrial genes, respectively, were developed and the protection elicited by the strains was evaluated in chickens against S. Enteritidis infection.
机译:肠炎沙门氏菌血清型肠炎沙门氏菌(肠炎沙门氏菌)被认为是流行病的蔓延,是对全世界人类健康的重大威胁。因此,已经做出了许多努力来确定暴发源并在农场中控制这种病原体。为促进流行病学调查,使用分型方法比较了从暴发和来源农场获得的肠炎链球菌的分离株,以确定人类暴发的感染源。当前,用于评估肠炎链球菌噬菌体类型(PT)4菌株的分子分型方法不能始终如一地证明不同爆发的菌株之间存在差异。为了提高肠炎沙门氏菌PT 4表征和流行病学研究的准确性,评估并比较了许多分子分型方法,以区分不同来源的肠炎沙门氏菌PT 4分离株。此外,由于肠炎沙门氏菌与食品安全性有关,已经进行了一些尝试来控制禽肠炎沙门氏菌感染。然而,目前可用的减毒和灭活的针对肠炎沙门氏菌的活疫苗显示肠炎沙门氏菌在内部器官,肠和盲肠中的定殖减少有限,从而对鸟类提供了不完全的保护。结果,迫切需要一种成功的疫苗来保护确保无肠炎沙门氏菌的食品,从而减少与食用受污染的鸡蛋和家禽产品相关的食源性疾病。分别开发了两种基于sefA和sefABCD纤维基因的活重组疫苗株,并评估了它们对鸡肠炎沙门氏菌感染的保护作用。

著录项

  • 作者单位

    University of Minnesota.;

  • 授予单位 University of Minnesota.;
  • 学科 Biology Molecular.; Biology Microbiology.; Biology Veterinary Science.
  • 学位 Ph.D.
  • 年度 2006
  • 页码 194 p.
  • 总页数 194
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 分子遗传学;微生物学;动物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号